Bryce Point Capital’s Keros Therapeutics KROS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-28,127
Closed -$445K 329
2024
Q4
$445K Buy
+28,127
New +$445K 0.13% 368